跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DESVENLAFAXINE SANDOZ desvenlafaxine 50mg modified release tablets bottle - TGA Drug Approval Details
Approvals
/
TGA
/
DESVENLAFAXINE SANDOZ desvenlafaxine 50mg modified release tablets bottle
Approved
STANDARD
DESVENLAFAXINE SANDOZ desvenlafaxine 50mg modified release tablets bottle
Medis Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
21d260681a243893
Company
Medis Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
21d260681a243893
Product Name
DESVENLAFAXINE SANDOZ desvenlafaxine 50mg modified release tablets bottle
Artg Id
218077
Artg Name
DESVENLAFAXINE SANDOZ desvenlafaxine 50mg modified release tablets bottle
Sponsor
Medis Pharma Pty Ltd
Company Detail Path
/organization/medis-pharma-pty-ltd
Artg Date
2014-11-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/cc8e8d3f43c0998b7478c061f5c25ee8.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
21d260681a243893
Type
Standard
Back to TGA Approvals